ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,919Medicare Part D Prescriptions Filled, Including Refills

Rank: 104 out of 2680

$1.29M Total Retail Price of All Prescriptions

Rank: 26 out of 2680

324 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
98% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 324 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

6% of this provider’s 324 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

1% of this provider’s 10,604 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

56% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$108 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

37 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
NEXIUM 376 330 1 19
CRESTOR 327 301 2 15
CREON 270 257 3 112
LIDODERM 257 248 4 74
LOVAZA 248 219 5 47
ZOLPIDEM TARTRATE 222 206 6 17
FUROSEMIDE 213 185 7 7
METOPROLOL TARTRATE 206 183 8 8
AMLODIPINE BESYLATE 203 178 9 3
PLAVIX 190 176 10 41
METOPROLOL SUCCINATE 172 136 11 11
CARVEDILOL 165 157 12 27
CLOPIDOGREL 157 134 13 30
ISOSORBIDE MONONITRATE ER 153 144 14 57
SIMVASTATIN 145 129 15 1
ALLOPURINOL 138 117 16 42
OMEPRAZOLE 135 119 17 2
BENICAR HCT 135 123 17 125
CLOTRIMAZOLE-BETAMETHASONE 127 115 19 109
DIOVAN HCT 125 117 20 54
ATORVASTATIN CALCIUM 123 107 21 10
METFORMIN HCL 117 116 22 6
MECLIZINE HCL 115 103 23 105
LUNESTA 115 89 23 297
ACTOS 111 98 25 98
BYSTOLIC 107 99 26 104
CELEBREX 106 104 27 75
ZOVIRAX 106 102 10 27 301
LEVOTHYROXINE SODIUM 105 102 29 4
LOSARTAN-HYDROCHLOROTHIAZIDE 100 88 30 46
IBUPROFEN 98 87 31 63
TAMSULOSIN HCL 98 80 31 25
SYNTHROID 90 79 33 39
ADVAIR DISKUS 86 61 34 32
POTASSIUM CHLORIDE 83 78 35 29
CHLORHEXIDINE GLUCONATE 83 76 35 166
BENICAR 81 64 37 122
AVODART 79 62 38 165
CLONIDINE HCL 79 70 38 84
SOLARAZE 77 75 40 172
ULORIC 77 73 40 320
TRICOR 73 57 42 115
ESCITALOPRAM OXALATE 69 54 43 82
DICYCLOMINE HCL 68 60 44 267
JANUMET 66 60 45 83
VOLTAREN 65 61 46 103
ATENOLOL 64 58 47 14
LIPITOR 62 46 48 78
PROAIR HFA 62 46 48 52
MICARDIS 60 60 50 219
RANEXA 57 57 51 173
MICARDIS HCT 57 49 51 205
DEXILANT 57 49 51 133
DIOVAN 56 56 54 26
VENTOLIN HFA 56 46 54 61
JANUVIA 54 54 56 34
ZETIA 53 49 57 69
LANSOPRAZOLE 52 44 58 121
RANITIDINE HCL 52 52 58 35
LISINOPRIL 52 44 58 5
EXFORGE 52 38 58 139
LEXAPRO 51 48 62 218
ENDOCET 51 28 S2 62 180
FAMOTIDINE 50 42 64 65
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.